Pharma Focus Asia

Repligen

LATEST NEWSRead more...

16

Jul 2024

Sabin Vaccine Institute Initiates Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine

Sabin Vaccine Institute has launched a Phase clinical trial for its vaccine against Sudan ebolavirus at Makerere University Walter Reed Project in Uganda This strain of ebolavirus lacks approved vaccines and was involved in a recent outbreak that resulted in significant fatalities According to the...

16

Jul 2024

Argenx and Zai Lab Receive Approval for Efgartigimod Alfa Injection in China for Generalized Myasthenia Gravis

Argenx SE and Zai Lab Limited announced today that Chinas National Medical Products Administration has granted approval for the Biologics License

15

Jul 2024

Everest Medicines Announces Successful Phase 3 Trial Results for Etrasimod in Treating Moderately-to-Severely Active Ulcerative Colitis in Asia

Everest Medicines has announced positive results from the maintenance phase of a Phase clinical trial of etrasimod in Asia for moderatelytoseverely active ulcerative colitis

13

Jul 2024

Merck Starts Commercial Production of First GMP-Compliant Cell Culture Media Manufacturing Line in China

Merck a global leader in science and technology has initiated the commercial production of its first GMP compliant manufacturing line for cell culture media in China

12

Jul 2024

Sanyou Bio and BioGeometry Join Forces to Develop AI-Powered Antibody Drug Discovery Platform

BioGeometry and Sanyou Bio have announced a strategic partnership to advance drug research and development BioGeometry known for its AIdriven protein design and Sanyou Bio a leader in innovative

12

Jul 2024

ADM Korea Launches First Clinical Trial of Niclosamide-Based Anticancer Drug for Prostate Cancer Patients Resistant to Hormone Therapy

ADM Korea a subsidiary of Hyundai Bioscience has announced plans to initiate clinical trials for their niclosamidebased oral metabolic anticancer drug targeting prostate cancer patients

Solovpe

press releasesRead more...

16

Jul 2024

Diakonos Oncology Receives FDA Fast Track Designation for Pancreatic Cancer Dendritic Cell Vaccine; Names Daniel D. Von Hoff, M.D. to Scientific Advisory Board

Diakonos Oncology Corporation a clinical stage immunooncology company announced today that the US Food and Drug Administration has granted Fast Track designation

16

Jul 2024

Acquisition of Amolyt Pharma completed

AstraZeneca today announced the successful completion of the acquisition of Amolyt Pharma a clinicalstage biotechnology company focused on developing novel treatments for rare endocrine diseases The acquisition bolsters the Alexion AstraZeneca Rare Disease latestage pipeline and expands on its bone...

15

Jul 2024

First Type 1 Diabetes Patient Enrolled in Rise Therapeutics' Latest Clinical Trial

Rise Therapeutics a clinicalstage biotechnology company developing novel oral immunotherapeutic medicines today announced that it has enrolled its first patient in its R placebo controlled blinded Phase b type diabetes clinical trial Gary Fanger President and Chief Executive Officer of Rise Therape...

13

Jul 2024

FDA Grants Fast Track Designation to 9MW2821 for the Treatment of Patients with Locally Advanced or Metastatic Nectin-4 Positive TNBC

Mabwell an innovative biopharmaceutical company with entire industry chain announces that its selfdeveloped novel Nectintargeting ADC has been granted Fast Track Designation

12

Jul 2024

MEKanistic Therapeutics Inc.'s First-in-Class Dual EGFR and PI3K Investigational Therapy, MTX-531, Demonstrates Significant Tolerability and Durable Tumor Regressions

MEKanistic Therapeutics Inc a biotechnology company pioneering the development of nextgeneration kinase inhibitors for cancer treatment

12

Jul 2024

First Patient Dosed in Phase I Clinical Trial of YOLT-201

YolTech Therapeutics a biotech company developing in vivo gene editing therapies to treat rare genetic diseases announced today the successful enrollment of the first patient in the Phase I clinical trial of YOLT its independently developed in vivo gene editing therapy

30 - 01

Jul 2024

30 - 01

Jul 2024

chemical indonesia

jakarta barat, Indonesia

30 - 01

Jul 2024

Inalab 2023

Jakarta Barat, Indonesia

13 - 14

Aug 2024

ADVANCING BUSINESS, TECHNOLOGY AND INNOVATION

Songdo Convensia, Incheon, South Korea

13 - 14

Aug 2024

12 YEARS OF EXCELLENCE: SOUTH KOREA’S BIOLOGICS

Songdo Convensia, Incheon, South Korea

19 - 21

Aug 2024
MFA + MMA 2024
4th Annual Cleaning Validation 2024
2nd Annual Pharma Impurity Conclave 2024
CPHI Korea 2024
World Orphan Drug Congress Europe 2024
Thermo Fisher - Drug Discovery and the impact of mAbs

TOP ARTICLES

KNOWLEDGE BANK

  • Interviews

    Innovation Management at Bachem

    Chief Technology Officer, Bachem Holding AG

    Gnther Loidl joined Bachem in He held several functions in Research and Development RD and Active Pharmaceutical Ingredient Manufacturing and became Vice President RD in Since he is CTO of the Bachem Group and a member of the Corporate Executive Committee He studied chemistry in Regensburg Germany and Leeds UK and obtained his doctorate under the supervision of Luis Moroder at the Max Planck In...
  • Articles

    Untapped Opportunities in Southeast Asia

    Southeast Asia is a growing pharmaceutical market with an increase in clinical trials in recent years With a population of about million and a total area of million kilometres it contains the regions wellrecognised study destinations of Malaysia Singapore and Thailand who are also members of PICS the Pharmaceutical Inspection Cooperation Scheme B

  • Techno Trends

    World\'s Smallest Pacemaker Implant by Medtronic

    IntroductionMedtronic has announced the latest innovation in advanced pacing technology and device miniaturization the first US implant of the worlds smallest pacemaker the MicraTM Transcatheter Pacing System TPSThe tiny pacemaker was implanted at NYU Medical Center as part of the Medtronic global pivo

EDITORIAL SECTION